IGM Biosciences (IGMS)
(Delayed Data from NSDQ)
$1.31 USD
+0.04 (3.15%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.31 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, IGM Biosciences, Inc. has a market cap of $76.35M, which represents its share price of $1.27 multiplied by its outstanding shares number of 60.12M. As a small-cap company, IGMS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IGMS 1.31 +0.04(3.15%)
Will IGMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IGMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IGMS
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
IGMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Other News for IGMS
IGM Biosciences (IGMS) Shares Surge After Acquisition Announcement
IGM Biosciences climbs on merger deal with Concentra
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1. ...
IGM Biosciences be acquired by Concentra for $1.247 in cash per share
IGM Biosciences moved to No Rating at BofA